Biotech
Coronavirus Vaccines and Treatments Move Toward Human Trials
As we approach four months since the start of the coronavirus (COVID-19) pandemic, many Biotechnology companies are quickly moving towards clinical trial phase of several vaccines and treatments. Biotechnology company news At the start of this month (April 2020) Novavax, a Maryland-based biotech company, said it would begin human trials in Australia in mid-May for
April 16, 2020
